Integrated Filing — IndAS



General information about company

Scrip Code 543573
NSE Symbol SYRMA
MSEI Symbol NOTLISTED
ISIN INE0DYJ01015
Name of company SYRMA SGS TECHNOLOGY LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 29-01-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-01-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Electronics Manufacturing Services
Start date and time of board meeting 29-01-2026   14:00:00
End date and time of board meeting 29-01-2026   17:00:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 2
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Company has not defaulted in any loan or debt securities



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 1,15,139.40 3,14,642.80
Other income 1,262.60 2,978.00
Total income 1,16,402.00 3,17,620.80
2 Expenses
(a) Cost of materials consumed 85,690.50 2,40,836.40
(b) Purchases of stock-in-trade 5,070.70 5,418.40
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (4,387.20) (5,806.40)
(d) Employee benefit expense 3,923.40 11,557.60
(e) Finance costs 624.00 3,175.50
(f) Depreciation, depletion and amortisation expense 1,649.50 5,135.20
(f) Other Expenses
1 Other expenses 12,112.30 29,840.50
Total other expenses 12,112.30 29,840.50
Total expenses 1,04,683.20 2,90,157.20
3 Total profit before exceptional items and tax 11,718.80 27,463.60
4 Exceptional items (260.50) (260.50)
5 Total profit before tax 11,458.30 27,203.10
6 Tax expense
7 Current tax 2,171.70 6,117.90
8 Deferred tax (44.40) (163.00)
9 Total tax expenses 2,127.30 5,954.90
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 9,331.00 21,248.20
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 9,331.00 21,248.20
17 Other comprehensive income net of taxes 15.00 (35.90)
18 Total Comprehensive Income for the period 9,346.00 21,212.30
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 19,258.80 19,258.80
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 4.84 11.43
Diluted earnings (loss) per share from continuing operations 4.84 11.42
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 4.84 11.43
Diluted earnings (loss) per share from continuing and discontinued operations 4.84 11.42
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. Earning per share not annualised except for the year ended Macrh 31, 2025. 2. The detailed notes to the unaudited standalone financial results are available in the outcome in pdf filed with the Stock Exchanges.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss (15.00) 35.90
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 15.00 (35.90)





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Walker Chandiok & Co LLP Yes 31-05-2028


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 26-08-2022
Amount Raised 84,012.60
Report filed for Quarter ended 31-12-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CRISIL Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review NA
Comments of the auditors, if any None
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Funding Capital expenditure for development of R&D facility/expansion/setting of manufacturing facilities NA 40,300.00 0.00 35,176.60 0.00 The Balance amount shall be utilized as per proposed schedule duly considering the current progress
2 Funding Working capital requirements NA 13,158.00 0.00 13,151.30 0.00 The Balance amount shall be utilized as per proposed schedule duly considering the current progress
3 General Corporate Purpose NA 19,114.20 0.00 19,000.00 0.00 The Balance amount shall be utilized as per proposed schedule duly considering the current progress


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (2)

Amount in (Lakhs)

Mode of Fund Raising QIP
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 12-08-2025
Amount Raised 1,00,000.00
Report filed for Quarter ended 31-12-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CARE Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review NA
Comments of the auditors, if any NA
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Repayment and/or pre-payment, in full or in part, of certain outstanding borrowings availed by our Company NA 75,000.00 0.00 75,000.00 0.00 All the proceeds received have been utilised in accordance with the placement doccuments as on December 31, 2025
2 General corporate purposes NA 22,426.20 0.00 22,426.20 0.00 All the proceeds received have been utilised in accordance with the placement doccuments as on December 31, 2025
3 Issue Related Expenses NA 2,573.80 0.00 2,573.80 0.00 All the proceeds received have been utilised in accordance with the placement doccuments as on December 31, 2025


Signatory Details

Name of signatory Bijay Kumar Agrawal
Designation of person Chief Financial Officer
Place Bijay Kumar Agrawal
Date 29-01-2026